Methocarbamol

Methocarbamol on the U.S. market: products, makers and brands

How Methocarbamol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

63 companies list 212 Methocarbamol product records with the FDA, mostly as tablet, injection, oral suspension; the earliest marketing or approval year on record is 1957. Brand names on the directory include Robaxin, Tanlor, Atmeksi and 1 more; the rest are generics.

Also listed with the FDA, not a patient dose form: Powder (17) · Kit (1) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Methocarbamol is used (Medicaid data)

A general measure of how commonly Methocarbamol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Methocarbamol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

How commonly is Methocarbamol prescribed? Of the 1,601 medications we measure, Methocarbamol ranks #97 by Medicaid prescriptions — more than 94% of them.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Methocarbamol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 42 of 1,064 listed Methocarbamol NDCs with Medicaid activity.

Compare Methocarbamol products

A representative set of FDA-listed product records for Methocarbamol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 212 products — FDA National Drug Code Directory. See every product, package size and price: browse all 212 Methocarbamol NDCs →

💵 What Methocarbamol costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Methocarbamol brand names

Methocarbamol is sold under 4 brand names in the FDA directory — Robaxin, Tanlor, Atmeksi, Methocarb 500-EZS. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Who makes Methocarbamol: manufacturers and labelers

63 companies list Methocarbamol products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, A-S Medication Solutions, PD-Rx Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

…and 39 more on the FDA NDC directory.

Methocarbamol compared with similar medicines

Medicines in the same class as Methocarbamol that we cover: Metaxalone, Dantrolene, Orphenadrine, Carisoprodol, Chlorzoxazone, Cyclobenzaprine. The table compares what the FDA directory records for each — how it is sold, the dose forms on the market, how many companies list it (makers, repackagers and distributors), and the earliest FDA record on file. Same class does not mean interchangeable; your prescriber chooses among them for reasons the label alone does not show.

Source: FDA National Drug Code Directory and Drugs@FDA, as summarized on each medicine's page. A dash means the fact is not on record.